SageView Advisory Group’s Veracyte VCYT Stock Holding History

SageView Advisory Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-221	Closed	-$9.3K	–	2343
2025 Q4	$9.3K	Buy	+221	New	+$8.91K	﹤0.01%	1742

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

SageView Advisory Group's VCYT Position: Q1 2026 in Review

SageView Advisory Group sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 221 shares — an estimated $9.3K sold.

SageView Advisory Group first reported a position in VCYT in Q4 2025 and held it in 1 quarter. The position peaked at $9.3K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

SageView Advisory Group reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 221 Veracyte shares in Q1 2026, an estimated $9.3K.
SageView Advisory Group first reported a position in Veracyte in Q4 2025 and held it in 1 quarter.
SageView Advisory Group's Veracyte position peaked at $9.3K in Q4 2025.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.